NCT03739073

Brief Summary

Prospective interventional study, open, non-comparative and non-randomized. The research concerns physiological parameters of the coronary and ocular blood circulation. At the coronary level, the curves of pressure and Doppler flow will be extracted from ComboMap® (Philips). The coronary microvascular resistances, basal and hyperemic, will be determined by the average ratio of the distal pressure and flow. At the ocular level, a fundus oculi and an OCTA (angiography by tomography in optical coherence) examination will be performed. The measures of the FFR and the coronary microvascular resistance will be determined by a guidewire allowing measures of pressure and by a guidewire allowing measures of Doppler flow (ComboWire®, Volcano), in 123 patients with intermediate stenosis of the left anterior descending artery (LDA). Topological parameters characterizing the retinal area and choriocapillaries will be determined by statistical approaches and mathematical morphology. To establish a predictor of the coronary microvascular resistance from the eye vascular parameters, we shall use a non-linear regression by supervised machine learning. The main cardiovascular risk factors (hypertension, diabetes, dyslipidemia, age, sex) will be part of predetermined input features for the machine learning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P25-P50 for not_applicable coronary-artery-disease

Timeline
Completed

Started Oct 2018

Longer than P75 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 5, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 13, 2018

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2024

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

5.5 years

First QC Date

November 5, 2018

Last Update Submit

December 13, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Coronary microvascular resistance results (Combowire)

    Estimed by Combowire During coronary angiography, coronary resistance will be measured by pressure and Doppler guides in patients with intermediate coronary stenosis according to the usual procedure. Correlation between results of Combowire® coronary microvascular resistance and OCTA ophthalmologic findings. A machine learning technique will be used to analyze this series of ocular data and to determine a predictor of post-treatment coronary microvascular resistance.

    Day 1

  • Coronary microvascular resistance results (OCTA)

    Estimated by ophthalmological examinations data from OCTA. An examination of fundus of the eye will then be performed by optical coherence tomography angiography without injection PLEX Elite 9000. Correlation between results of Combowire® coronary microvascular resistance and OCTA ophthalmologic findings. A machine learning technique will be used to analyze this series of ocular data and to determine a predictor of post-treatment coronary microvascular resistance.

    Day 1

Secondary Outcomes (5)

  • angiographical stenosis

    Day 1

  • Fractional Flow Reserve (FFR)

    Day 1

  • coronary microvascular resistance (CFR)

    Day 1

  • microvascular resistance values

    Year 1

  • total area of flow signal void on the choriocapillaris layer

    Year 1

Study Arms (1)

Patient with coronary arterial indication

EXPERIMENTAL

A fundus oculi and an OCTA (angiography by tomography in optical coherence) examination will be performed for patients with intermediate stenosis of the left anterior descending artery (LDA).

Other: OCTA (angiography by tomography in optical coherence)

Interventions

The study concerns patients with intermediate stenosis of the left anterior descending artery (LDA). A fundus oculi and an OCTA (angiography by tomography in optical coherence) examination will be performed; it's a non-invasive imaging test. OCT uses light waves to take cross-section pictures of your retina and then ophthalmological examination data will correlate with coronary angiography.

Patient with coronary arterial indication

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female patient's ≥18 years of age with coronary arterial indication as usual and with proximal and / or mean IVA stenosis ≥ 50%.
  • Signed informed consent
  • Affiliation to the social security system

You may not qualify if:

  • Unstable Coronary Artery Disease
  • Atrial fibrillation
  • History of myocardial infarction \<6 months in the territory of the proximal and / or mean IVA.
  • Asthma
  • Aortocoronary bypass surgery.
  • Collateral development at the level of the proximal and / or mean IVA.
  • Allergy to iodine, severe renal insufficiency.
  • Ametropia\> = 6 diopters.
  • History of retinal ocular pathologies other than uncomplicated diabetic retinopathy and hypertensive retinopathy.
  • History of ophthalmic treatments such as macular or panretinal laser photocoagulation, intravitreal injection of anti-VEGF or cortisone.
  • Chronic glaucoma
  • Patients under guardianship or curators.
  • Pregnant or lactating women.
  • Patient's not affiliated to the French social security.
  • Persons placed under the protection of justice,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon - Hopital de la Croix Rousse

Lyon, 69004, France

Location

Related Publications (1)

  • Harbaoui, B. (2021). Arterial stiffness, physiology, and relevance of interventional cardiology procedures (Habilitation à diriger des recherches thesis). Université Claude Bernard Lyon 1. (Manuscript hosted by CREATIS/INSA Lyon; defense notice by Lyon 1).

    RESULT

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2018

First Posted

November 13, 2018

Study Start

October 4, 2018

Primary Completion

March 20, 2024

Study Completion

March 20, 2024

Last Updated

December 19, 2025

Record last verified: 2025-12

Locations